The following fair value hierarchy table presents information about the Company’s financial assets and liabilities measured at fair value (in thousands):



	Assets and Liabilities Measured at Fair Value on a Recurring Basis
June 30, 2015	Level 1		Level 2		Level 3		Total
Assets
Financial instruments owned, at fair value:
Equities ⁽¹⁾	$	2,391,499	$	—	$	—	$	2,391,499
Listed options	117,934		—		—		117,934
U.S. government and Non-U.S. government obligations	117,725		—		—		117,725
Corporate debt	68,213		—		—		68,213
Foreign currency forward contracts	—		355		—		355
Total Financial instruments owned, at fair value	2,695,371		355		—		2,695,726
Investment in CME Group ⁽²⁾	4,655		—		—		4,655
Other ⁽³⁾	—		64,406		—		64,406
Total assets held at fair value	$	2,700,026	$	64,761	$	—	$	2,764,787
Liabilities
Financial instruments sold, not yet purchased, at fair value:
Equities ⁽¹⁾	$	1,785,493	$	—	$	—	$	1,785,493
Listed options	93,113		—		—		93,113
U.S. government obligations	91,272		—		—		91,272
Corporate debt	68,279		—		—		68,279
Total liabilities held at fair value	$	2,038,157	$	—	$	—	$	2,038,157


⁽¹⁾	Equities of $826.5 million have been netted by their respective long and short positions by CUSIP number.


⁽²⁾	Investment in CME Group is included within Investments on the Consolidated Statements of Financial Condition.


⁽³⁾	Other consists of $62.8 million receivable from BATS related to the sale of KCG Hotspot and $1.6 million of deferred compensation investments which are included within Other assets and Investments, respectively, on the Consolidated Statements of Financial Condition.



	Assets and Liabilities Measured at Fair Value on a Recurring Basis
December 31, 2014	Level 1		Level 2		Level 3		Total
Assets
Financial instruments owned, at fair value:
Equities ⁽¹⁾	$	2,479,910	$	—	$	—	$	2,479,910
Listed options	144,586		—		—		144,586
U.S. government and Non-U.S. government obligations	22,983		—		—		22,983
Corporate debt ⁽²⁾	59,832		—		—		59,832
Foreign currency forward contracts	—		60		—		60
Total Financial instruments owned, at fair value	2,707,311		60		—		2,707,371
Investment in CME Group ⁽³⁾	4,435		—		—		4,435
Other investments ⁽³⁾	—		1,014		—		1,014
Total assets held at fair value	$	2,711,746	$	1,074	$	—	$	2,712,820
Liabilities
Financial instruments sold, not yet purchased, at fair value:
Equities ⁽¹⁾	$	2,069,342	$	—	$	—	$	2,069,342
Listed options	115,362		—		—		115,362
U.S. government obligations	18,953		—		—		18,953
Corporate debt ⁽²⁾	82,050		—		—		82,050
Total liabilities held at fair value	$	2,285,707	$	—	$	—	$	2,285,707

⁽¹⁾ Equities of $743.1 million have been netted by their respective long and short positions by CUSIP number.

⁽²⁾Corporate debt instruments of $0.3 million have been netted by their respective long and short positions by CUSIP number.

⁽³⁾ Investment in CME Group and Other investments, which primarily consist of deferred compensation investments, are included within Investments on the Consolidated Statements of Financial Condition.